Viewing Study NCT02071368


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-02-22 @ 5:23 PM
Study NCT ID: NCT02071368
Status: COMPLETED
Last Update Posted: 2014-07-01
First Post: 2014-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy View
None Canagliflozin View
None Metformin View
None JNJ-28431754 View
None GLUMETZA® View
None Bioequivalence View
None Fixed Dose Combination View